| __timestamp | ACADIA Pharmaceuticals Inc. | Merck & Co., Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 60602000 | 7180000000 |
| Thursday, January 1, 2015 | 73869000 | 6704000000 |
| Friday, January 1, 2016 | 99284000 | 7194000000 |
| Sunday, January 1, 2017 | 149189000 | 9982000000 |
| Monday, January 1, 2018 | 187163000 | 9752000000 |
| Tuesday, January 1, 2019 | 240385000 | 9872000000 |
| Wednesday, January 1, 2020 | 319130000 | 13397000000 |
| Friday, January 1, 2021 | 239415000 | 12245000000 |
| Saturday, January 1, 2022 | 361575000 | 13548000000 |
| Sunday, January 1, 2023 | 351619000 | 30531000000 |
Infusing magic into the data realm
In the competitive world of pharmaceuticals, research and development (R&D) spending is a key indicator of innovation and future growth. Over the past decade, Merck & Co., Inc. and ACADIA Pharmaceuticals Inc. have showcased contrasting strategies in their R&D investments. From 2014 to 2023, Merck's R&D expenses surged by over 300%, peaking at a staggering $30.5 billion in 2023. This reflects Merck's commitment to maintaining its leadership in the industry through robust innovation.
Conversely, ACADIA Pharmaceuticals, while significantly smaller, has shown a consistent upward trend in its R&D spending, growing by nearly 500% over the same period. This growth underscores ACADIA's ambition to expand its footprint in the pharmaceutical landscape. The data highlights the diverse approaches these companies take in their quest for medical breakthroughs, with Merck leveraging its vast resources and ACADIA focusing on strategic growth.
Comparing Innovation Spending: Merck & Co., Inc. and Bristol-Myers Squibb Company
R&D Insights: How Merck & Co., Inc. and Regeneron Pharmaceuticals, Inc. Allocate Funds
Merck & Co., Inc. or United Therapeutics Corporation: Who Invests More in Innovation?
Merck & Co., Inc. vs CRISPR Therapeutics AG: Strategic Focus on R&D Spending
Research and Development Expenses Breakdown: Merck & Co., Inc. vs Bausch Health Companies Inc.
Research and Development Expenses Breakdown: Merck & Co., Inc. vs Wave Life Sciences Ltd.
Comparing Innovation Spending: Merck & Co., Inc. and Galapagos NV
Research and Development Expenses Breakdown: Sarepta Therapeutics, Inc. vs ACADIA Pharmaceuticals Inc.
Comparing Innovation Spending: Blueprint Medicines Corporation and ACADIA Pharmaceuticals Inc.
Who Prioritizes Innovation? R&D Spending Compared for ACADIA Pharmaceuticals Inc. and Iovance Biotherapeutics, Inc.
Comparing Innovation Spending: ACADIA Pharmaceuticals Inc. and Dynavax Technologies Corporation
ACADIA Pharmaceuticals Inc. vs Celldex Therapeutics, Inc.: Strategic Focus on R&D Spending